This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Peptides & Oligonucleotides

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Events

Showing 4 of 7 eventsView all events

TIDES Digital Week: Oligonucleotide & Peptide Therapeutics

May 17-20, 2021

Industry leaders & service providers uncover leading strategies for expediting R&D and improving CMC efficiency

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

June 1-3 & September 14 -16, 2021, Online Training Course

LEARN HOW TO DEVELOP AN EVOLVING ANALYTICAL CONTROL STRATEGY FOR YOUR OLIGONUCLEOTIDE DRUG SUBSTANCE

Introduction to Oligonucleotide Conjugate Strategies

June 8-10 & October 26-28, 2021, Online Training Course

Understand how to best design Oligonucleotide conjugates from simple starting building blocks to the full oligonucleotide conjugate

Next Generation CAR & T Cell Therapies

June 22-24, 2021, Pacific Standard Time (PST)

CAR AND T CELL THERAPIES: IMPROVE THE SAFETY & EFFICACY OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Articles & Video

Showing 9 of 58 articles & videoView all articles & video
Premium
Antibodies

Emerging Therapies Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.

Featured
Personalized Medicine

eBook: Personalized Peptide Vaccines & Therapies

This ebook focuses on the latest challenges and approaches in producing personalized therapies and vaccines to fight cancer and rare diseases.

Webinar Series

A look back at TIDES Asia Virtual Scientific Forum 2021

We explore the best of on-demand webinars from this year's TIDES Asia Virtual Scientific Forum.

Peptides and Oligonucleotides

Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021

How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.

Drug Delivery

Delivery is still biggest area of need in peptide, oligonucleotide and mRNA therapeutics

MRNA Therapeutics

Scaling up manufacturing when it’s needed most

Oligonucleotides

Analytical and regulatory CMC strategies for oligonucleotide therapeutics

Diversity and Inclusion

SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021

Peptides and Oligonucleotides

TIDES Europe Virtual 2020: Post-event Report

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 40,000+ TIDES executives and scientists, including 2,000+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Michael Dunnet, Head of Portfolio Sales:
michael.dunnet@informa.com | +1 (857) 504-6732

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Subscribe to our monthly Peptides & Oligonucleotides newsletter

Get the latest content and updates straight to your inbox

Copyright © 2021 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.